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Improved Management of
Neutropenic Enterocolitis
Using Early Ultrasound Scan
and Vigorous Medical
Treatment
To the Editor—Neutropenic enterocol-
itis is a life-threatening complication in
hematological patients, with an associated
mortality rate of 29.5%–50% [1, 2]. Po-
lymicrobic infiltrates in the inflamed
bowel wall with subsequent necrotizing
perforations and systemic dissemination
of infectious agents are the terminal events
[1–4]. Bowel wall thickening, well detected
by modern imaging techniques, is the true
warning sign [1–7]. Data on the clinical
impact of new strategies for early diagnosis
of disease and for treatment of these pa-
tients are scanty [5]. We prospectively in-
vestigated whether ultrasound-driven vig-
orous medical treatment could improve
outcome in patients with neutropenic
enterocolitis.
Since 2000, we have systematically per-
formed high-resolution ultrasound with
dynamic tissue harmonic technology
(EUB 6500; Hitachi) and a 2–5 MHz
broad-band convex probe (EUB 514 C
probe; Hitachi) at patients’ bedsides to
evaluate intestinal thickness within 12 h
after the appearance of severe neutropenia,
fever, and abdominal pain or diarrhea
among 500 patients treated with intensive
chemotherapy for hematological malig-
nancies. Overall, 25 consecutive adult pa-
tients (5%; 10 male and 15 female patients;
20 with acute leukemia and 5 with lym-
phoma) with evidence by ultrasound of
wall thickness5 mm (median wall thick-
ness, 6 mm; range, 5–20 mm) in the small
bowel (12 patients), the large bowel (7 pa-
tients), and both (6 patients) were diag-
nosed as having neutropenic enterocolitis.
The patients promptly received ceftazi-
dime (6 g/day), amikacin (1 g/day), tei-
coplanin (400 mg/day), metronidazole
(0.5–1 g/day), amphotericin B (1–1.5 mg/
kg/day intravenously), granulocyte col-
ony-stimulating factor, and total paren-
teral nutrition for a median duration of
10 days (range, 7–15 days). In all 25 pa-
tients, the follow-up ultrasound demon-
strated progressive reduction of intestinal
mural thickening, along with symptom
disappearance. Before 2000, in our insti-
tution, ultrasound was used only to doc-
ument abnormal bowel wall thickening
(median thickness, 11 mm; range, 6–20
mm) in 25 patients who had already re-
ceived a clinical diagnosis of neutropenic
enterocolitis (i.e., neutropenic fever; sig-
nificant abdominal pain requiring anal-
gesics, usually in the right lower quadrant;
and3 bloody diarrhea stools daily). The
median time between the appearance of
fever and the diagnosis of neutropenic en-
terocolitis was 9 days (range, 5–11 days)
before 2000 versus 3 days (range, 1–5
days) in 2000 and after, thus allowing ear-
lier administration of antimicrobial ther-
apy ( , by Mann-Whitney U test).Pp .01
Consequently, 4 patients had invasive fun-
gal infections (Candida albicans was found
in blood samples from 2 patients by cul-
ture, and 2 patients had histological and
microbiological evidence of Aspergillus fu-
migatus in bowel specimens available after
surgical resection) before 2000, and no pa-
tient had fungal pathogen isolates in 2000
or after. Remarkably, 12 (48%) of 25 pa-
tients died of acute abdomen and/or shock
due to severely necrotizing neutropenic
enterocolitis before 2000. In contrast,
none of the 25 patients in the systematic
ultrasound era died until day 30 after che-
motherapy ( , by log-rank test).P ! .001
Our study reveals that the systematic
use of high-resolution ultrasound as part
of the work-up of patients with neutro-
penic fever and cancer is particularly val-
uable to identify neutropenic enterocolitis
at an early stage, when conservative treat-
ment would be maximally effective [8]. A
bowel wall thickness5 mm was the prag-
matic criterion to start vigorous medical
treatment. At this time, the administration
of broad-spectrum antimicrobial therapy,
in addition to granulocyte colony-stimu-
lating factor and bowel rest, may signifi-
cantly reduce neutropenic enterocolitis–
related morbidity and mortality.
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Table 1. Bocavirus and other pathogens
isolated in nasopharyngeal aspirate spec-
imens from 50 children (age, 2–15 years)
hospitalized with severe acute asthma
during the winter season 2005–2006.
Pathogen
No. of patients
from whom
the pathogen
was isolated
Mycoplasma pneumoniae 7
Bocavirusa 7
Respiratory syncytial virus 5
Human metapneumovirus 3
Influenza A virus 3
Influenza B virus 1
Adenovirus 0
Parainfluenza viruses 0
No pathogen identified 24
a One case was associated with respiratory syn-
cytial virus, and 1 case was associated with human
metapneumovirus.
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Human Bocavirus in Children
with Acute Asthma
To the Editor—Allander et al. [1] have
reported their study of human bocavirus
(HBoV) in children with acute wheezing.
Other authors have also revealed that bo-
cavirus is present in nasopharyngeal as-
pirate specimens from children with re-
spiratory tract infection with or without
wheezing. All authors have found a pre-
dominance of young infants, mainly !2
years of age, in their results [2–4]. The
majority of the published studies are ret-
rospective, based on specimens that were
frozen after they were obtained from hos-
pitalized infants, with a clinical hetero-
geneity among patients and a great num-
ber of virus in the youngest infants (an
age group that is commonly hospitalized
with acute respiratory tract infection).
For several years, we have checked for
Mycoplasma pneumoniae and respiratory
viruses in children hospitalized with acute
asthma [5]. Because a real-time PCR is
available in our virology unit, we inves-
tigated prospectively the presence of
HBoV in nasopharyngeal aspirate speci-
mens from children aged 2–15 years who
were hospitalized with severe acute asthma
from 1 October 2005 through 1 May 2006.
All children were known to be asthmatic
and were hospitalized after an observation
period in the emergency unit because of
failure of treatment with repeated inhaled
bronchodilators and hypoxia, as previ-
ously described [5].
Nasopharyngeal aspirate specimens
were tested for common viral respiratory
pathogens by direct immunofluorescence
assays with monoclonal antibodies to re-
spiratory syncytial virus, influenza A and
B viruses, adenovirus, and parainfluenza
type 1, 2, and 3 viruses. Specimens were
also inoculated into HUH7 and A549 cell
monolayers for virus isolation. PCR for
detection of M. pneumoniae and human
metapneumovirus were also performed.
The first PCR for HBoV was a conven-
tional PCR targeting the VP2 gene, using
a forward primer with a sequence 5′-CAG-
TGGTACCAGACACCAGAAG and a re-
verse primer with a sequence 5′-GCCAG-
TTCTTTGTTGCGTATCT. The PCR
products were analyzed by agarose gel
electrophoresis. The second PCR assay was
a real-time PCR assay that targets the
HBoV NS1 gene. Specific primers and
probe were defined from the reported se-
quences of the NS1 gene at positions 953–
1029 of the HBoV strain st1 (GenBank
accession no. DQ000495) and were ob-
tained from bocavirus r-gene (Argene). A
specimen was considered to contain
HBoV only if the results of PCR were pos-
itive for both regions VP2 and NS1.
The results of PCR performed for 50
hospitalized children with acute asthma
(29 male and 21 female children) are
shown in table 1. The numbers of patients
infected with M. pneumoniae, respiratory
syncytial virus, and influenza viruses were
expected because of previous studies in the
same hospital unit [5]. Three of 50 chil-
dren were infected with human meta-
pneumovirus. HBoV was identified in na-
sopharyngeal aspirate specimens from 7 of
50 hospitalized children and was associ-
ated with respiratory syncytial virus in 1
patient and with human metapneumovi-
rus in 1 patient. The median age of pa-
tients infected with HBoV was 3 years; 1
of 7 patients was 15 years of age, and 4
of 7 patients were male.
Our data reveal that HBoV is a com-
mon cause of severe exacerbation of
asthma in children. The respiratory infec-
tion is not limited to young infants, and
children aged 12 years are commonly
infected.
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